NCIt definition : A recombinant, chimeric, human-murine monoclonal antibody directed against the alpha
subunit of the interleukin-2 receptor (IL-2R alpha) with immunosuppressant activity.
Basiliximab selectively binds to and blocks IL-2R alpha, expressed on the surface
of activated T-lymphocytes, thereby preventing interleukin-2 binding and inhibiting
the interleukin-2-mediated activation of lymphocytes.;
UNII : 9927MT646M;
CAS number : 179045-86-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 179045-86-4
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;